Valuation: Omnicell, Inc.

Capitalization 2.03B 1.75B 1.6B 1.51B 2.8B 196B 2.84B 18.98B 7.43B 92.73B 7.63B 7.47B 323B P/E ratio 2026 *
57.3x
P/E ratio 2027 * 45.2x
Enterprise value 2.03B 1.75B 1.6B 1.51B 2.8B 196B 2.84B 18.98B 7.43B 92.73B 7.63B 7.47B 323B EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.55x
Free-Float
76.31%
Yield 2026 *
-
Yield 2027 * -
1 day-0.32%
1 week+1.11%
Current month+6.92%
1 month+20.50%
3 months+11.94%
6 months+23.01%
Current year-2.24%
1 week 42.46
Extreme 42.46
45
1 month 35.5
Extreme 35.5
46.89
Current year 31.75
Extreme 31.75
55
1 year 26.84
Extreme 26.845
55
3 years 22.66
Extreme 22.66
77.14
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 2002-09-30
Director of Finance/CFO 56 2025-09-14
Chief Operating Officer 50 2024-10-06
Director TitleAgeSince
Director/Board Member 70 2012-12-31
Director/Board Member 70 2013-12-31
Chairman 68 1992-08-31
Change 5d. change 1-year change 3-years change Capi.($)
-0.38%+1.11%+61.98%-40.68% 2.03B
-2.29%+2.84%-31.63%-2.81% 26.92B
-0.19%+5.64%-54.59%+112.86% 9.63B
+1.18%+6.40%-15.02%+56.49% 5.61B
+0.79%-15.01% - - 2.36B
+4.65%-12.67% - - 1.67B
+2.20%+2.01%-33.22% - 1.23B
-4.16%-5.90%-23.29%-49.39% 945M
-4.08%-5.36%-29.34%-1.51% 842M
0.00%-1.04%+7.95%-61.13% 808M
Average -0.17%-2.73%-14.64%+1.97% 5.2B
Weighted average by Cap. -0.93%+2.73%-29.50%+24.53%

Financials

2026 *2027 *
Net sales 1.25B 1.07B 982M 928M 1.71B 120B 1.74B 11.64B 4.55B 56.87B 4.68B 4.58B 198B 1.32B 1.13B 1.04B 978M 1.81B 127B 1.84B 12.27B 4.8B 59.97B 4.94B 4.83B 209B
Net income 35.72M 30.71M 28.12M 26.56M 49.09M 3.45B 49.87M 333M 130M 1.63B 134M 131M 5.67B 45.83M 39.41M 36.07M 34.08M 62.98M 4.43B 63.99M 428M 167M 2.09B 172M 168M 7.28B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,525
Date Price Change Volume
26-05-21 44.49 $ -0.51% 33,377
26-05-20 44.72 $ +2.05% 373,580
26-05-19 43.82 $ +1.39% 454,546
26-05-18 43.22 $ +0.23% 436,443
26-05-15 43.12 $ -1.55% 549,735
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
44.72USD
Average target price
61.29USD
Spread / Average Target
+37.04%

Quarterly revenue - Rate of surprise